IF1 Protein Controls Aging Rate

Michael David Forrest
DOI: https://doi.org/10.1101/2021.10.28.466310
2024-05-02
Abstract:IF1 protein inhibits F F ATP hydrolysis (and not F F ATP synthesis). Across investigated species more IF1 protein, and less F F ATP hydrolysis, correlates with greater maximal lifespan. Increased IF1 protein, and decreased F F ATP hydrolysis, safely reduces a biomarker of aging in mice. Body temperature decrease, in mice administered with a small molecule drug that selectively inhibits F F ATP hydrolysis (which doesn’t inhibit F F ATP synthesis), is evidence that F F ATP hydrolysis is used for metabolic heat generation . Instrumental to homeothermy, which is a new fundamental discovery. A further discovery is that cancer cells subvert F F ATP hydrolysis to drive their distinctive Warburg metabolism and so selective drug inhibition of F F ATP hydrolysis exerts potent anticancer activity. When the body is in an ambient temperature of 37°C (or more), no metabolic heat generation is needed for the body to be at 37°C, and so a large dose of a F F ATP hydrolysis inhibiting anticancer drug may be administered, which may slow aging. So, here might be an entirely new class of anticancer drugs that may (when appropriately used) help, instead of harm, normal cells. Distinct from present anticancer drugs, which greatly harm normal cells, causing horrific side-effects, which kill many and cause many others to abandon cancer treatment. In short, this paper teaches how mammals metabolically generate heat, why different mammal species have different maximal lifespans, and new anticancer drugs, that are predicted to slow aging.
Pharmacology and Toxicology
What problem does this paper attempt to address?